Physician profile
Chelsea Zimmerman
NPI 1205223617
$28,900.71
in general payments reported to CMS, 2019-2025
42 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $175 · 2022: $1,042 · 2023: $1,528 · 2024: $9,677 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $4,761 · Education: $10.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,787.25 |
| Food and Beverage | $4,760.68 |
| Education | $10.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $23,386.93 | 2021-2025 | |
| Novo Nordisk INC | $808.24 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Xeris Pharmaceuticals, INC. | $657.11 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Tolmar, INC. | $392.85 | 2023-2025 | Fensolvi |
| Lilly USA, LLC | $369.19 | 2022-2025 | Jardiance, Lyumjev, Humalog |
| Ascendis Pharma Endocrinology INC | $334.89 | 2022-2025 | Skytrofa |
| Tandem Diabetes Care, INC. | $301.53 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $213.60 | 2022-2025 | Lupron Depot |
| Beta Bionics, INC. | $201.77 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Insulet Corporation | $190.36 | 2023-2025 | Omnipod |
| Radius Health, INC. | $177.59 | 2023-2025 | Tymlos |
| Corcept Therapeutics | $173.47 | 2022-2025 | Korlym |
| Mannkind Corporation | $162.43 | 2021-2025 | Afrezza |
| Abbott Laboratories | $126.37 | 2023-2025 | Freestyle Libre 3 |
| Medtronic Minimed, INC. | $125.99 | 2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $109.26 | 2021-2025 | |
| Dexcom, INC. | $99.65 | 2022-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $90.94 | 2021-2025 | Minimed 780g |
| Amneal Pharmaceuticals LLC | $83.71 | 2021-2024 | Unithroid |
| Lifescan, INC. | $78.29 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $69.11 | 2024-2025 | |
| Ultragenyx Pharmaceutical INC. | $66.07 | 2021-2023 | |
| Kyowa Kirin, INC. | $64.01 | 2023-2024 | Crysvita |
| Pfizer INC. | $57.18 | 2024-2025 | |
| Sequel Med Tech, LLC | $54.87 | 2025 | Twiist |
| Intuity Medical INC | $51.76 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $45.95 | 2022 | |
| Neurocrine Biosciences, INC. | $41.12 | 2024-2025 | |
| Ibsa Pharma INC. | $41.01 | 2023-2024 | Tirosint, Licart, Tirosint |
| Eton Pharmaceuticals, INC. | $39.90 | 2023-2025 | Alkindi, Increlex, Khindivi |
| Soleno Therapeutics, INC. | $37.73 | 2025 | Vykat Xr |
| Rhythm Pharmaceuticals, INC. | $25.91 | 2023 | Imcivree |
| Amryt Pharma Holdings Ltd | $25.47 | 2023 | |
| Recordati_rare_diseases_inc. | $24.74 | 2022 | |
| Eusa Pharma (US) LLC | $24.74 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.38 | 2023 | Strensiq |
| Azurity Pharmaceuticals, INC. | $22.54 | 2025 | Triptodur |
| Averitas Pharma INC. | $22.12 | 2025 | Qutenza |
| Ionis Pharmaceuticals, INC. | $21.90 | 2025 | Tryngolza |
| Becton, Dickinson and Company | $21.65 | 2022 | |
| Embecta Corp. | $19.37 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Biomarin Pharmaceutical INC. | $15.01 | 2024 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsea Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.